LG-2527 is a nonsteroidal progestin which was under development by Ligand Pharmaceuticals and Wyeth for the treatment of menopausal symptoms and breast cancer, but was never marketed.[1] It reached the preclinical stage of development prior to the discontinuation of its development in early 2001.[1]
This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it.
Strategi Solo vs Squad di Free Fire: Cara Menang Mudah!
